Laboratory parameters in adolescent patients aged 12-17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial
BRITISH JOURNAL OF DERMATOLOGY(2024)
关键词
adolescents,biochemistry,eosinophils,moderate-to-severe,tralokinumab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要